Azzoli CG - Search Results

1

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.

Paik PK, James LP, Riely GJ, Azzoli CG, Miller VA, Ng KK, Sima CS, Heelan RT, Kris MG, Moore E, Rizvi NA. Paik PK, et al. Among authors: azzoli cg. Cancer Chemother Pharmacol. 2011 Nov;68(5):1331-7. doi: 10.1007/s00280-011-1621-0. Epub 2011 Apr 3. Cancer Chemother Pharmacol. 2011. PMID: 21461889 Free PMC article. Clinical Trial.

2

Chemotherapy for early stage non-small cell lung cancer.

Kris MG, Azzoli CG. Kris MG, et al. Among authors: azzoli cg. Lung Cancer. 2001 Dec;34 Suppl 3:S49-52. doi: 10.1016/s0169-5002(01)00372-5. Lung Cancer. 2001. PMID: 11740994 Review.

3

Trastuzumab in the treatment of non-small cell lung cancer.

Azzoli CG, Krug LM, Miller VA, Kris MG, Mass R. Azzoli CG, et al. Semin Oncol. 2002 Feb;29(1 Suppl 4):59-65. doi: 10.1053/sonc.2002.31526. Semin Oncol. 2002. PMID: 11894015 Review.

4

Targeting lethal minimal residual disease in small cell lung cancer.

Patel JD, Krug LM, Azzoli CG, Gomez J, Kris MG, Miller VA. Patel JD, et al. Among authors: azzoli cg. Semin Oncol. 2003 Feb;30(1):79-85. doi: 10.1053/sonc.2003.50018. Semin Oncol. 2003. PMID: 12635092 Review.

5

A phase I trial of perillyl alcohol in patients with advanced solid tumors.

Azzoli CG, Miller VA, Ng KK, Krug LM, Spriggs DR, Tong WP, Riedel ER, Kris MG. Azzoli CG, et al. Cancer Chemother Pharmacol. 2003 Jun;51(6):493-8. doi: 10.1007/s00280-003-0599-7. Epub 2003 Apr 15. Cancer Chemother Pharmacol. 2003. PMID: 12695855 Clinical Trial.

6

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

Krug LM, Azzoli CG, Kris MG, Miller VA, Khokhar NZ, Tong W, Ginsberg MS, Venkatraman E, Tyson L, Pizzo B, Baez V, Ng KK, Sirotnak FM. Krug LM, et al. Among authors: azzoli cg. Clin Cancer Res. 2003 Jun;9(6):2072-8. Clin Cancer Res. 2003. PMID: 12796370 Clinical Trial.

7

Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.

Azzoli CG, Miller VA, Ng KK, Krug LM, Hensley ML, O'Reilly EM, Muller RJ, Kris MG. Azzoli CG, et al. Am J Clin Oncol. 2003 Jun;26(3):247-51. doi: 10.1097/01.COC.0000017782.24458.DD. Am J Clin Oncol. 2003. PMID: 12796593 Review.

8

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Miller VA, et al. J Clin Oncol. 2004 Mar 15;22(6):1103-9. doi: 10.1200/JCO.2004.08.158. J Clin Oncol. 2004. PMID: 15020612

9

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.

Krug LM, Crapanzano JP, Azzoli CG, Miller VA, Rizvi N, Gomez J, Kris MG, Pizzo B, Tyson L, Dunne M, Heelan RT. Krug LM, et al. Among authors: azzoli cg. Cancer. 2005 May 15;103(10):2128-31. doi: 10.1002/cncr.21000. Cancer. 2005. PMID: 15812822 Free article. Clinical Trial.

10

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.

Fury MG, Krug LM, Azzoli CG, Sharma S, Kemeny N, Wu N, Kris MG, Rizvi NA. Fury MG, et al. Among authors: azzoli cg. Cancer Chemother Pharmacol. 2006 May;57(5):671-7. doi: 10.1007/s00280-005-0080-x. Epub 2005 Aug 31. Cancer Chemother Pharmacol. 2006. PMID: 16136310 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters